OECDReference EN/AU/PS1103921
Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack and Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack
Official information organised for easier consultation. The source publication remains authoritative.
Identification
Product identification
- Product
- Dasatinib Dr. Reddy's dasatinib 50 mg film coated tablet blister pack and Dasatinib Dr. Reddy's dasatinib 100 mg film coated tablet blister pack
Official information
Risk and measures
- Risk or hazard
- The tablet may not dissolve properly and this can result in incomplete release of the medicine. If patients receive a lower dose of the medicine than prescribed, the medicine may be less effective, increasing the risk of serious adverse health effects.
- Recommendations
- Consumers should check whether their medicine is from the affected batches and contact their pharmacist or healthcare provider to make arrangements to return the product for a refund. Do not stop or alter your prescribed treatment. Make an appointment with your physician to discuss alternative treatment options. For more details, see https://apps.tga.gov.au/Prod/sara/arn-detail.aspx?k=RC-2022-RN-01209-1 For further information, contact Dr. Reddys Laboratories Australia by phone on 0427 306 107 or via the website at https://www.drreddys.com/australia/contact-us/
Official information
Economic operators
- Manufacturer
- Dr. Reddys Laboratories Australia Pty Ltd
Territory
Geography
- Distribution
- Retirada en Australia
- Country of recall
- Australia
Provenance and context
NagameAlert distinguishes content published by the source from its organisation and normalisation. Values marked “NagameAlert” belong to that processing layer. Always check measures, scope and updates in the official publication.